Anthony D Ho Selected Research

Lymphoma (Lymphomas)

1/2020	Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
10/2019	Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis.
1/2018	Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result.
9/2017	The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin's lymphomas.
10/2016	Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation.
1/2016	Polycomb Protein BMI1 Regulates Osteogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Downstream of GSK3.
1/2016	Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma.
1/2016	BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
8/2014	Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma.
2/2013	Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony D Ho Research Topics

Disease

50	Multiple Myeloma 01/2018 - 09/2002
45	Neoplasms (Cancer) 01/2023 - 01/2002
24	Leukemia 01/2023 - 01/2002
23	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2003
18	Lymphoma (Lymphomas) 01/2020 - 01/2002
15	Immunoglobulin Light-chain Amyloidosis 01/2018 - 12/2003
13	Amyloidosis 01/2018 - 12/2004
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 12/2003
11	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2005
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 05/2006
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2016 - 01/2002
9	Chromosome Aberrations (Chromosome Abnormalities) 01/2016 - 05/2008
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 12/2003
7	Infections 09/2017 - 08/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 12/2002
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2002
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2018 - 05/2008
6	Body Weight (Weight, Body) 10/2017 - 01/2002
6	Paraproteinemias (Monoclonal Gammopathy) 01/2012 - 12/2003
5	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 01/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 07/2009
4	Disease Progression 06/2018 - 12/2005
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014 - 04/2007
4	Hodgkin Disease (Hodgkin's Disease) 02/2013 - 04/2006
4	Breast Neoplasms (Breast Cancer) 04/2006 - 01/2002
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 09/2005
3	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2004
3	Blast Crisis (Blast Phase) 12/2018 - 04/2007
3	Testicular Neoplasms (Testicular Cancer) 10/2017 - 04/2008
3	Autoimmune Diseases (Autoimmune Disease) 07/2016 - 07/2004
3	Hairy Cell Leukemia 01/2016 - 05/2003
3	Inflammation (Inflammations) 06/2010 - 03/2008
3	Pathologic Complete Response 10/2009 - 12/2003
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2009 - 01/2007
2	Trisomy (Trisomies) 01/2023 - 01/2018
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2018 - 11/2010
2	Chylous Ascites 09/2016 - 08/2009
2	Residual Neoplasm 04/2016 - 11/2011
2	Weight Loss (Weight Reduction) 10/2015 - 05/2015
2	Pneumonia (Pneumonitis) 08/2015 - 06/2010

Drug/Important Bio-Agent (IBA)

20	Rituximab (Mabthera)FDA Link 09/2017 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 10/2006
12	Melphalan (Alkeran)FDA LinkGeneric 11/2017 - 12/2004
11	AntigensIBA 11/2017 - 11/2004
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017 - 01/2003
10	Lenalidomide (CC 5013)FDA Link 01/2018 - 01/2009
9	Amyloid (Amyloid Fibrils)IBA 01/2018 - 12/2003
7	SteroidsIBA 01/2018 - 08/2011
6	Bortezomib (Velcade)FDA Link 01/2018 - 01/2010
6	purineIBA 01/2015 - 05/2003
5	Chimeric Antigen ReceptorsIBA 01/2023 - 10/2016
5	CytokinesIBA 12/2018 - 09/2002
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017 - 08/2006
5	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2016 - 04/2006
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016 - 10/2006
5	plerixafor FDA Link 02/2015 - 08/2006
5	Pentostatin (Nipent)FDA LinkGeneric 01/2015 - 05/2003
5	Imatinib Mesylate (Gleevec)FDA Link 06/2014 - 12/2002
5	Thalidomide (Thalomid)FDA Link 03/2013 - 09/2002
4	Phosphotransferases (Kinase)IBA 01/2018 - 09/2006
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 05/2008
4	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 01/2002
4	Glucose (Dextrose)FDA LinkGeneric 07/2009 - 03/2004
3	EnzymesIBA 06/2018 - 06/2010
3	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2004
3	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 10/2006
3	Aldehyde DehydrogenaseIBA 01/2017 - 12/2009
3	Vincristine (Oncovin)FDA LinkGeneric 08/2015 - 05/2008
3	Alkylating AgentsIBA 01/2015 - 04/2006
3	Etoposide (VP 16)FDA LinkGeneric 08/2014 - 04/2007
3	Peptides (Polypeptides)IBA 01/2013 - 04/2006
3	Arginine (L-Arginine)FDA Link 01/2013 - 06/2010
3	ArginaseIBA 01/2013 - 09/2006
3	pericentrinIBA 06/2009 - 11/2003
2	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 08/2003
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 06/2007
2	Monoclonal AntibodiesIBA 01/2018 - 08/2003
2	Transaminases (Aminotransferases)IBA 11/2017 - 10/2010
2	Bendamustine Hydrochloride FDA Link 01/2017 - 12/2016
2	Azacitidine (5 Azacytidine)FDA Link 01/2017 - 08/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2016 - 03/2005

Therapy/Procedure

54	Therapeutics 01/2021 - 09/2002
50	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
48	Stem Cell Transplantation 01/2023 - 01/2002
10	Transplantation 01/2022 - 12/2003
10	Immunotherapy 06/2018 - 11/2004
7	Hematopoietic Stem Cell Transplantation 01/2020 - 12/2003
6	Radiotherapy 10/2017 - 03/2004
6	Autologous Transplantation 01/2016 - 01/2007
4	Cell Transplantation 01/2023 - 03/2016
4	Hematopoietic Stem Cell Mobilization 11/2017 - 12/2014
3	Salvage Therapy 01/2016 - 10/2006
3	Aftercare (After-Treatment) 07/2013 - 05/2003
2	Homologous Transplantation 01/2019 - 01/2015
2	Immunomodulation 01/2018 - 01/2015
2	Photopheresis 01/2018 - 03/2015
2	Heart Transplantation (Grafting, Heart) 11/2017 - 10/2009